Alert detail
LCD L39682: MolDX: Molecular Testing for Risk Stratification of Thyroid Nodules — Noridian
What changed
New Molecular Testing LCD for Thyroid Nodules by Noridian.
Who’s affected: Endocrinology billing teams · Effective: February 5, 2026
Primary source: View the official CMS/MAC document ↗
Get the action steps and full analysis
This change affects 7 billing codes.
The full analysis, the revision comparison and the as-of-date version of this policy are what a partner packet carries. The source document above is free and always will be.